Naughty Flicks

Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPROLivestreamMenuHere are the biggest calls on Wall Street on Thursday: Truist initiates Nebius as buy Truist says it sees margin upside. “We are initiating coverage of Nebius with a Buy rating and $355 PT. We view Nebius as an opportunity to invest in a scaling AI-native hyperscaler still building out its infrastructure.” Deutsche Bank initiates Clover Health as buy Deutsche says the Medicare Advantage healthcare provider has plenty more room to run. “We are initiating coverage of CLOV s hares with a Buy rating and a $6 price target.” Wells Fargo upgrades Synopsys to overweight from equal weight Wells says the company is firing on all cylinders. “We [upgrade] SNPS t o OW as improving AI demand momentum & accel’ing results into F2027 can drive shares higher. We expect its 9/30 A-Day to provide: 1) positive initial F2027 guide slightly above street est; 2) positive update on LT model re-accel.” Wells Fargo upgrades Yum Brands to overweight from equal weight Wells says buy the dip. “Upgrade YUM t o OW; Despite NT uncertainty, we see a compelling LT entry point for a high-quality asset poised to re-rate as EPS growth accelerates & TB recovers from transitory setbacks.” Morgan Stanley initiates Revolution Medicine as overweight Morgan Stanley says the company has a differentiated offering. “Revolution Medicines is building what we believe is the leading RAS- targeted oncology franchise in a market where RAS mutations drive ~30% of all cancers and represent an addressable pool of ~100,000 patients annually in key solid tumors today, including pancreatic, lung, and colorectal cancer.” TD Cowen initiates Relx as buy TD Cowen says the business analytics company is an AI beneficiary. “We believe the market has misclassified RELX as an AI casualty when its proprietary data, embedded workflows, and trusted decision tools make it an AI beneficiary.” Goldman Sachs initiates Abivax as buy Goldman says it sees a “blockbuster opportunity” for the biotech company. “We initiate coverage of Abivax with a Buy rating and 12m price targets of €132/ADR $155.” Raymond James upgrades Casey’s General Stores to outperform from market perform Raymond James says buy the dip. “We are upgradin g CASY to Outperform from Market Perform and establishing a $750 target price following the ~14% post-earnings pullback, which we believe creates an attractive entry point into a high-quality compounder with an underlying earnings algorithm that remains intact.” KBW upgrades Simmons First National to outperform from market perform KBW said in its upgrade o f Simmons that shareholders should buy the weakness in the regional bank. “In light of last week’s expense announcement followed by a pretty minimal stock reaction, we are upgrading the shares to Outperform as we see multiple ways the stock can win going forward.” Oppenheimer initiates Aehr Test Systems as outperform Oppenheimer says the company is undervalued. “We initiate AEHR with Outperform and a $120 PT. Aehr’s burn-in systems stress test chips for early failures before deployment or costly packaging.” JPMorgan initiates SK Hynix as overweight JPMorgan says the company has “AI cycle durability.” “We initiate coverage o f SK hynix ADR (SKHY) with an OW rating and a Jun-27 PT of US$245 based on a 20% ADR premium to the local share price target.” William Blair initiates Clean Harbors as outperform William Blair says the company is a reshoring and data center beneficiary. “Clean Harbors’ hazardous waste incinerators are often a top discussion point for investors as they represent over 60% of commercial capacity in North America. However, incinerators are one piece of an industry-leading network of collection, transportation, processing and treatment, and disposal assets…” Canaccord initiates 908 Devices as buy The firm says the chemical analysis company is firing on all cylinders. “908 Devices develops handheld and tabletop chemical analysis equipment that lets frontline personnel detect, identify, and monitor thousands of hazardous substances in the field faster than transporting samples to laboratories for testing.” Piper Sandler reiterates SpaceX as neutral Piper says it’s concerned that Starship launches might ramp up “too slowly.” “We think SPCX may embrace the role of enabler, to dispel anti-trust concerns.” BTIG initiates Amer Sports as buy BTIG says the sporting goods company is underappreciated. ” AS stands out as a multi-brand sportswear platform delivering strong 20%+ top-line growth near-term, and LDD to mid-teens % growth over the medium term, with each of its brands still relatively early in their growth cycles.” JPMorgan upgrades Meta to overweight from neutral The firm also raised its price target to $820 per share from $640. “We believe there’s still meaningful upside potential as Meta is in the early stages of releasing frontier models and AI-driven products beyond advertising, notably Muse AI agent and Meta Model API access.” Read more. Piper Sandler initiates Nvidia, Broadcom, Arm and Advanced Micro Devices as overweight The firm says it’s very bullish on all four stocks. “Top picks include AVGO , NVDA in Accelerators, where demand is 2x supply. Market share gainers in CPU servers we like AMD and ARM.” Read more. Stifel initiates Matador Resources as buy Stifel says the oil and energy exporation company has plenty of upside. “We view Matador as an underappreciated SMID cap Delaware pure play with unrecognized value for its San Mateo midstream asset that continues to benefit from growing gas processing and water disposal constraints in the basin.” RBC initiates Stepstone Group as outperform RBC says the investment advice company has earnings power. ” STEP’ s de-rating in 2026 has created an attractive entry point into a capital-light business…” Morgan Stanley downgrades Nike to underweight from equal weight The firm reinstated coverage and says it’s overvalued. “For NKE, we think consensus embeds too much growth too soon – particularly in China – while valuation still reflects more of the old NKE/sportswear landscape than today’s fragmented market.” RBC upgrades Paccar to outperform from sector perform RBC says investors should buy the weakness. “Since late July, PACCAR has underperformed the sector by ~7ppts, despite positive earnings momentum. In our view, this creates an attractive entry point for a stock highly geared to the nascent North American recovery.” Bank of America reiterates Apple as buy Bank of America lowered its price target to $370 per share from $380 following the company’s iPhone product unveil on Wednesday. “In his first major product launch as CEO, Mr. Ternus emphasized Apple’s long-standing focus on building reliable products that combine hardware, software and services to deliver differentiated user experiences.” JPMorgan reiterates Tesla as neutral The firm said in a note on Thursday that Tesla faces an uncertain path to regulator approval for the Cybercab. “With the official public roll-out of the Cybercab, the debate no longer pertains to whether the vehicle can drive itself but whether a controls-free, purpose-built platform can clear an authorization landscape that remains deeply fragmented across jurisdictions.” Morgan Stanley upgrades TC Energy and DT Midstream to overweight from equal weight Morgan Stanley says it sees “attractive value” for both stocks. “We believe natural gas pipeline stocks currently offer some of the most attractive value within midstream, with upcoming project announcements likely to catalyze outperformance through year-end. Raising DTM and TRP to OW (from EW).” Bernstein initiates XPO, Knight-Swift and Saia as outperform The firm says it’s bullish on all three trucking and freight companies. ” Knight-Swift i s the cleanest way to own the truckload rate reset; XPO is our preferred LTL idea, with Saia offering the higher-beta alternative.” Wolfe upgrades Kymera Therapeutics to outperform from peer perform Wolfe said in its upgrade of Kymera that the biotech company has several positive catalysts ahead. “Despite stock valuation, the debate is trending favorably.” StoneX upgrades Block to buy from hold StoneX says the company has a “reinvigorated ” business model. “We observe that Block’s reorganization and leveraging of agentic AI has reinvigorated a business model that had been widely regarded as stagnating. Wolfe initiates Louisiana-Pacific as outperform Wolfe says growth is “terrific” for the homebuilder products company. “We initiate coverage of LPX with an Outperform rating and a $90 PT.” JPMorgan upgrades Herc Holdings to overweight from neutral The firm says it sees earnings upside for the equipment rental company. “We are upgrading HRI to Overweight from Neutral and establishing a Dec 27 PT of $175 (vs. $165 for Dec 26) based on ~5.8x FY28 EV/EBITDA and ~12x FY28 PE, as its valuation discount vs. its larger peers is wider than the historical average.” BTIG upgrades Orchestra BioMed to buy from neutral BTIG sayd the biotech company is “hitting its stride.” “We are upgrading our recommendation on Orchestra BioMed from Neutral to Buy and setting a $10 PT.” Morgan Stanley reiterates Ferrari as overweight The firm raised its price target to $460 per share from $442. “Ferrari’s expanding engagement platform strengthens our confidence in long-term demand, deepening client loyalty and collection building while reinforcing the value of belonging to the brand.”Read More